Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome
Ila R. Singh
, John E. Gorzynski
, Daria Drobysheva
, Leda Bassit
, Raymond F. Schinazi
Research output: Contribution to journal › Article › peer-review
49Scopus
citations
Fingerprint
Dive into the research topics of 'Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome'. Together they form a unique fingerprint.